Status:
COMPLETED
Effects of GCP on Prostate Cancer.
Lead Sponsor:
University of California, Davis
Conditions:
Prostate Cancer
Eligibility:
MALE
Phase:
NA
Brief Summary
Genistein Combined Polysaccharide (GCP) is derived from adding soy powder to shiitake mushrooms. This concentrated mixture is currently being sold in Japan and the United States and is thought to poss...
Eligibility Criteria
Inclusion
- Participants must be male and have a pathological diagnosis of prostate cancer.
- No treatment (surgery \[RRP\], radiation, or hormones) prior to study entry.
- The patient has decided, after consultation with his own doctor, to have no treatment intervention (surgery \[RRP\], radiation, or hormones) for the next six months.
- PSA between 2.0 and 10.0 ng/ml.
- If PSA is \>10.0, patient must have been on Active Surveillance for 12 months prior to study initiation.
- No known allergy to soy or soy products.
- The patient is not currently taking more than 2 grams of genistein a day in nutritional or diet enhancing supplements (OTC supplements).
- \-
Exclusion
- No pathological documentation of prostate cancer.
- Allergy to soy or soy products
- Prior history of treatment for prostate cancer.
- \-
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
End Date :
September 1 2006
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT00269555
Start Date
May 1 2004
End Date
September 1 2006
Last Update
June 29 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Davis
Sacramento, California, United States, 95817